Antidepressant-like effects in various mice strains in the tail suspension test

Behavioural Brain Research

Volumn 143, Issue 2, 2003, Pages 193-200

  Ripoll, Nadège ^a   David, Denis Joseph Paul ^a   Dailly, Eric ^a   Hascoët, Martine ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Animal models; Antidepressants; Genetic factors; Mice strains; Tail suspension test

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DESIPRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL GENETICS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG SENSITIVITY; EXPERIMENTAL MODEL; FUNCTION TEST; HEREDITY; IMMOBILIZATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0043095479     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(03)00034-2     Document Type: Article

References (34)

1. Bai F., Li X., Clay M., Lindstrom T., Skolnick P. Intra- and interstrain differences in models of "behavioral despair" Pharmacol. Biochem. Behav. 70:2001;187-192.
2. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N.et al. Behavioral phenotypes of inbred mouse strains: implications and recommandations for molecular studies. Psychopharmacology. 132:1997;107-124.
3. Crusio W.E., Schwegler H., Van Abeelen J.H. Behavioral and neuroanatomical divergence between two sublines of C57BL/6J inbred mice. Behav. Brain Res. 42:1991;93-97.
4. Dalvi A., Lucki I. Murine models of depression. Psychopharmacology. 147:1999;14-16.
5. David D.J.P., Níc Dhonnchadha B.A., Jolliet P., Hascoët M., Bourin M. Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? Behav. Brain Res. 119:2001;203-211.
6. David DPJ, Renard CE, Jolliet P, Hascoët M, Bourin M. Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology, in press.
7. 3H ]-tomoxetine Neuroscience Lett. 265:1999;151-154.
8. Jones B.C., Hou X., Cook M.N. Effect of exposure to novelty on brain monoamines in C57BL/6 and DBA/2 mice. Physiol. Behav. 59:1996;361-367.
9. Katkov Y.A., Otmakhova N.A., Gurevich E.V., Nesterova I.V., Bobkova N.V. Antidepressants suppress bulbectomy-induced augmentation of voluntary alcohol consumption in C57BL/6J but not in DBA/2 mice. Physiol. Behav. 56:1994;501-509.
10. Kelai S, Hamon M, Lanfumey L. Alcohol intake in two different mouse strains: modulation through cannabinoid receptors. In: Proceedings of the 6th meeting of the French Society of Pharmacology, 2002, Abstract Book. p. 244, 253.
11. Lerer B., Macciardi F. Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions. Int. J. Neuropsychopharmacol. 5(3):2002;255-275.
12. Liu X., Gershenfeld H.K. Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice. Biol. Psychiatry. 49:2001;575-581.
13. Martin P., Massol J., Colin J.N., Lacomblez L., Puech A. Antidepressant profile of bupropion and three metabolites in mice. Pharmacopsychiatry. 23:1990;187-194.
14. Mayorga A.J., Lucki I. Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology. 155:2001;110-112.
15. Perrault G., Morel E., Zivkovic B., Sanger D.J. Activity of lifoxetine and other serotonin uptake inhibitors in the tail suspension test in mice. Pharm. Biochem. 42:1992;45-57.
16. Porsolt R.D., Le Pichon M., Jalfre M. A new animal model sensitive to antidepressive treatments. Nature. 266:1977;730-732.
17. Porsolt R.D., Bertin A., Jalfre M. "Behavioural Despair" in rats and mice: strain difference and the effects of imipramine. Eur. J. Pharmacol. 51:1978;291-294.
18. Redrobe J.P., MacSweeney C.P., Bourin M. The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur. J. Pharmacol. 318:1996;213-220.
19. Redrobe J.P., Bourin M. Effects of pretreatment with clonidine, lithium and quinine on the activities of antidepressant drugs in the mouse tail suspension test. Fundam. Clin Pharmacol. 11:1997;381-386.
20. Redrobe J.P., Bourin M. Augmentation of antidepressant pharmacotherapy: a preclinical approach using the mouse force swimming test. CNS Spectrums. 4:1999;73-81.
21. Renard C.E., Fiocco A.J., Clenet F., Hascoët M., Bourin M. Is dopamine implicated in the antidepressant-like effect of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacology. 159:2001;42-50.
22. Rogers D.C., Jones D.N.C., Nelson P.R., Jones C.M., Quilter C.A., Robinson T.L.et al. Use of SHIRPA and discriminant analysis to characterize marked differences in the behavioural phenotype of six inbred mouse strains. Behav. Brain Res. 105:1999;207-217.
23. Sánchez C., Meier Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Psychopharmacology. 129:1997;197-205.
24. Sánchez C., Hyttel J. Comparison of effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell. Mol. Neurobiol. 19:1999;467-488.
25. Stéru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 85:1985;367-370.
26. Stéru L., Chermat R., Lenegre A., Mico J.A., Thierry B., Stéru M.et al. The automated tail suspension test: a computerised device which differentiates psychotropic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry. 11:1987;659-671.
27. Tatsumi M., Groshan K., Blakely R.D., Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur. J. Pharmacol. 340:1997;249-258.
28. Teste J.F., Pelsy-Johann I., Decelle T., Boulu R.G. Anti-immobility activity of different antidepressant drugs using the tail suspension test in normal or reserpinized mice. Fundam. Clin. Pharmacol. 7:1993;219-226.
29. Trullas R., Barrington J., Skolnick P. Genetic differences in a tail suspension test for evaluating antidepressant activity. Psychopharmacology. 99:1989;287-288.
30. Trullas R., Skolnick P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology. 111:1993;323-331.
31. Van der Heyden J.A.M., Molewijk E., Olivier B. Strain differences in response to drugs in the tail suspension test for antidepressant activity. Psychopharmacology. 92:1987;127-130.
32. Van Gaalen M.M., Steckler T. Behavioral analysis of four mouse strains in an anxiety test. Behav. Brain Res. 115:2000;95-106.
33. Vaugeois J.M., Passera G., Zuccaro F., Costentin J. Individual differences in response to imipramine in the mouse tail suspension test. Psychopharmacology. 134:1997;387-391.
34. Willner P. Animal models of depression: validity and applications. INIST CNRS, 1999.